When Politics Overpowers Science: Why the US Withholds LEN from South Africa
The US's Decision to Exclude South Africa from LEN Funding By excluding South Africa from its overseas funding for the roll-out of the revolutionary six-monthly HIV prevention jab, known as lenacapavir (LEN), the Trump administration undermines its own stated mission of helping other African countries, according to a US HIV activist. This decision has sparked significant criticism and concern within the global health community. In September, the US government announced that it would join the Global Fund to Fight Aids, TB and Malaria, to buy LEN for African countries with high HIV infection rates. The Trump administration described its support as a "market-shaping initiative" aimed at increasing LEN production and uptake, thereby bringing down the price of the jab as quickly as possible. However, the US government left South Africa off the list of 10 states it will fund, despite the country having the largest market for LEN due to its high number of new HIV infections. ...